(1S)-(+)-(Camphorylsulfonyl)oxaziridine
|
|
- CAS-Nr.
- 104322-63-6
- Englisch Name:
- (1S)-(+)-(Camphorylsulfonyl)oxaziridine
- Synonyma:
- (S)-(+)-(Camphorsulfonyl)Oxazi;(+)-(Camphorsulfonyl)oxaziridine;S-(10-Camphorsulfonyl)oxaziridine;(S)-(+)-(CAMPHORSULFONYL)OXAZIRIDINE;(S)-2,N-EPOXY-EXO-10,2-BORNANESULTAM;(+)-((CAMPHORYL)SULFONYL)OXAZIRIDINE;(S)-(+)-(Camphorylsulfonyl)oxaziridine;(1S)-(+)-(CAMPHORYLSULFONYL)OXAZIRIDINE;(1S)-(+)-(10-CAMPHORSULFONYL) OXAZIRINE;(1S)-(+)-(1-Camphorsulfonyl)oxaziridine
- CBNumber:
- CB3447891
- Summenformel:
- C10H15NO3S
- Molgewicht:
- 229.3
- MOL-Datei:
- 104322-63-6.mol
|
(1S)-(+)-(Camphorylsulfonyl)oxaziridine Eigenschaften
- Schmelzpunkt:
- 172-174 °C(lit.)
- alpha
- 45 º (c=2, chloroform)
- Siedepunkt:
- 317.6±25.0 °C(Predicted)
- Dichte
- 1.2486 (rough estimate)
- Brechungsindex
- 1.5060 (estimate)
- storage temp.
- 2-8°C
- Löslichkeit
- Chloroform (Sparingly), Methanol (Slightly)
- pka
- -11.75±0.40(Predicted)
- Aggregatzustand
- Crystals or Crystalline Powder
- Farbe
- White
- Optische Aktivität
- [α]28/D +45°, c = 2 in chloroform
- BRN
- 6274370
- CAS Datenbank
- 104322-63-6(CAS DataBase Reference)
(1S)-(+)-(Camphorylsulfonyl)oxaziridine Chemische Eigenschaften,Einsatz,Produktion Methoden
S-Sätze Betriebsanweisung:
S22:Staub nicht einatmen.
S24/25:Berührung mit den Augen und der Haut vermeiden.
Chemische Eigenschaften
(1S)-(+)-(Camphorylsulfonyl)oxaziridine is white crystall powder
Verwenden
(1S)-(+)-(Camphorylsulfonyl)oxaziridine is a useful synthetic intermediate. Used for asymmetric hydroxylation
(1S)-(+)-(Camphorylsulfonyl)oxaziridine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(1S)-(+)-(Camphorylsulfonyl)oxaziridine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 260)Lieferanten
104322-63-6()Verwandte Suche:
- (+)-(2R,8AS)-(CAMPHORYLSULFONYL)OXAZIRIDINE
- (2R,8AS)-(+)-(CAMPHORYLSULFONYL)OXAZIRIDINE
- (1S)-(+)-2,N-EPOXY-EXO-10,2-BORNANESULTAM
- (IS)-(+)-(10-Camphorsulfonyl)oxaziridine
- S-(10-Camphorsulfonyl)oxaziridine
- (4aS,7R,8aS)-9,9-DiMethyltetrahydro-4H-4a,7-Methanobenzo[c][1,2]oxazireno[2,3-b]isothiazole 3,3-dioxide
- (+)-(2R,8aS)-10-(CaMphorylsulfonyl)oxaziridine
- (4aS,7R,8aS)-Tetrahydro-9,9-diMethyl-4H-4a,7-Methanooxazirino[3,2-i][2,1]benzisothiazole 3,3-Dioxide
- (1S)-(+)-(Camphorylsulfonyl)oxaziridine, (1S)-(+)-2,N-Epoxy-exo-10,2-bornanesultam
- (1α,5β,7α)-10,10-Dimethyl-4,5-epoxy-3-thia-4-azatricyclo[5.2.1.01,5]decane3,3-dioxide
- (3aS)-9,9-Dimethyloctahydro-3aβ,6β-methano-1,7aα-epoxy-2,1-benzisothiazole 2,2-dioxide
- (4aS,7R,8aS)-5,6,7,8-Tetrahydro-9,9-dimethyl-4H-4a,7-methanooxazirino[3,2-i][2,1]benzoisothiazole 3,3-dioxide
- (4aS,7R,8aS)-9,9-Dimethyl-4H-4a,7-methanotetrahydrooxazirino[3,2-i][2,1]benzisothiazole 3,3-dioxide
- (8aS)-5,6,7,8-Tetrahydro-9,9-dimethyl-4H-4aβ,7β-methanooxazirino[3,2-i][2,1]benzisothiazole 3,3-dioxide
- (+)-(2R,8aS)-(Camphorylsulfonyl)oxaziridine,98+%
- (4AS,7R,8aS)-9,9-Dimethyltetrahydro-4H-4a,7-methanobenzo-[c][1,2]oxazireno[2,3-b]isothiazole 3,3-
- (1S)-(+)-(10-Camphorsulfonyl)oxaziridine
(1S)-(+)-(Camphorylsulfonyl)oxaziridine
- (S)-(+)-(Camphorylsulfonyl)oxaziridine
- (4AS,7R,8aS)-9,9-Dimethyltetrahydro-4H-4a,7-methanobenzo-[c][1,2]oxazireno[2,3-b]isothiazole 3
- (1S)-(+)-(CAMPHORYLSULFONYL)OXAZIRIDINE
- (1S)-(+)-(10-CAMPHORSULFONYL)OXAZIRIDINE
- (1S)-(+)-(10-CAMPHORSULPHONYL)OXAZIRIDINE
- (S)-(+)-(CAMPHORSULFONYL)OXAZIRIDINE
- (S)-2,N-EPOXY-EXO-10,2-BORNANESULTAM
- (+)-((CAMPHORYL)SULFONYL)OXAZIRIDINE
- (1S)-(+)-(10-Camphorsulfonyl)oxaziridine (1S)-(+)-2,N-Epoxy-exo-10,2-bornanesultam
- (+)-(2R,8aS)-(Camphorylsulfonyl)oxaziridine, 99+% ee, 99+%
- (S)-(+)-(Camphorsulfonyl)Oxazi
- (1S)-(+)-(10-CAMPHORSULFONYL) OXAZIRINE
- (2R 8AS)-(+)-(CAMPHORYLSULFONYL)OXAZIRIDINE [ASYMMETRIC OXIDIZING GR]
- (2R,8aS)-(+)-(Camphorylsulfonyl)oxaziridine [Asymmetric Oxidizing Reagent]
- (S)-(10-Camphorsulfonyl)oxaziridine,99%e.e.
- (+)-(2R, 8aS)-(Camphorylsulfonyl)oxaziridine, 99+%, (99+% e.e.)
- (1S)-(+)-(1-Camphorsulfonyl)oxaziridine
- (2R,8aS)-(+)-(Camphorylsulfonyl)oxaziridine[AsymmetricOxidizingReagent]>
- 4H-4a,7-Methanooxazirino[3,2-i][2,1]benzisothiazole, tetrahydro-9,9-dimethyl-, 3,3-dioxide, (4aS,7R,8aS)-
- CAS104322-63-6 (1S)-(+)-(Camphorylsulfonyl)oxaziridine
- (+)-(2R,8aS)-(Camphorylsulfonyl)oxaziridine
- (+)-(Camphorsulfonyl)oxaziridine
- (4aS,7S,8aS)-9,9-dimethyltetrahydro-4H-4a,7-methanobenzo[c][1,2]oxazireno[2,3-b]isothiazole 3,3-dioxide
- (1S,8R)-11,11-dimethyl-5-oxa-3λ?-thia-4-azatetracyclo[6.2.1.0?,?.0?,?]undecane-3,3-dione
- (1S,8R)-11,11-dimethyl-5-oxa-3λ?-thia-4-azatetracyclo[6.2.1.01,?.0?,?]undecane-3,3-dione
- 104322-63-6
- C10H15NO3S
- Hydroxylation
- Asymmetric Synthesis
- Sulfur Compounds (for Synthesis)
- Bicyclic Monoterpenes
- Oxidation
- Terpenes
- Chiral Catalysts, Ligands, and Reagents
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Chiral Reagents
- pharmacetical
- chiral
- Asymmetric Synthesis
- Bicyclic Monoterpenes